REVVITY INC

Revvity insider Vohra Tajinder S sold 7,330 shares at $140.88 on 9/16/26 under a 10(b)(5)(1) plan – a routine move that suggests continued confidence in Revvity’s growth.

Revvity insider move shows estate‑planning, not a market shift—focus on its biotech platform, licensing deals and partner drug‑dev prospects for investors.

Insider sale: Revvity CAO Anita Gonzales sells 85 shares at $109.48 – a routine, plan‑based move amid steady growth and 8.4% YTD gain. Explore the details.

Insider sale at Revvity Inc. shows a routine tax‑withholding, not a red flag – executive confidence stays strong while the biotech firm pushes AI‑driven growth.

Insider trading at Revvity Inc. shows routine 10‑b5‑1 buys‑sell for Vohra Tajinder S, suggesting balanced risk‑management, not bullish bets, as earnings, sentiment, and valuation trends drive the stock.